150 related articles for article (PubMed ID: 2000261)
1. Importance of peroxisomes in the formation of chenodeoxycholic acid in human liver. Metabolism of 3 alpha,7 alpha-dihydroxy-5 beta-cholestanoic acid in Zellweger syndrome.
Kase BF; Pedersen JI; Wathne KO; Gustafsson J; Björkhem I
Pediatr Res; 1991 Jan; 29(1):64-9. PubMed ID: 2000261
[TBL] [Abstract][Full Text] [Related]
2. In vivo and vitro studies on formation of bile acids in patients with Zellweger syndrome. Evidence that peroxisomes are of importance in the normal biosynthesis of both cholic and chenodeoxycholic acid.
Kase BF; Pedersen JI; Strandvik B; Björkhem I
J Clin Invest; 1985 Dec; 76(6):2393-402. PubMed ID: 4077985
[TBL] [Abstract][Full Text] [Related]
3. Defective peroxisomal cleavage of the C27-steroid side chain in the cerebro-hepato-renal syndrome of Zellweger.
Kase BF; Björkhem I; Hågå P; Pedersen JI
J Clin Invest; 1985 Feb; 75(2):427-35. PubMed ID: 3973012
[TBL] [Abstract][Full Text] [Related]
4. Role of peroxisomes in the biosynthesis of bile acids.
Björkhem I; Kase BF; Pedersen JI
Scand J Clin Lab Invest Suppl; 1985; 177():23-31. PubMed ID: 3865345
[TBL] [Abstract][Full Text] [Related]
5. Formation of chenodeoxycholic acid from 3 alpha, 7 alpha-dihydroxy-5 beta-cholestanoic acid by rat liver peroxisomes.
Prydz K; Kase BF; Björkhem I; Pedersen JI
J Lipid Res; 1986 Jun; 27(6):622-8. PubMed ID: 3746130
[TBL] [Abstract][Full Text] [Related]
6. Human hepatoblastoma cells (HepG2) and rat hepatoma cells are defective in important enzyme activities in the oxidation of the C27 steroid side chain in bile acid formation.
Farrants AK; Nilsson A; Pedersen JI
J Lipid Res; 1993 Dec; 34(12):2041-50. PubMed ID: 8301225
[TBL] [Abstract][Full Text] [Related]
7. Bile acids and bile alcohols in two patients with Zellweger (cerebro-hepato-renal) syndrome.
Délèze G; Björkhem I; Karlaganis G
J Pediatr Gastroenterol Nutr; 1986; 5(5):701-10. PubMed ID: 3761102
[TBL] [Abstract][Full Text] [Related]
8. Bile acid profiles in peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency.
Clayton PT; Patel E; Lawson AM; Carruthers RA; Collins J
J Clin Invest; 1990 Apr; 85(4):1267-73. PubMed ID: 2318981
[TBL] [Abstract][Full Text] [Related]
9. Competitive inhibition of side chain oxidation of 3 alpha, 7 alpha-dihydroxy-5 beta-cholestan-26-oic acid by 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestan-26-oic acid in the hamster.
Cass OW; Williams GC; Hanson RF
J Lipid Res; 1980 Feb; 21(2):186-91. PubMed ID: 7373160
[TBL] [Abstract][Full Text] [Related]
10. In vitro formation of bile acids from di- and trihydroxy-5 beta-cholestanoic acid in human liver peroxisomes.
Kase BF; Prydz K; Björkhem I; Pedersen JI
Biochim Biophys Acta; 1986 Jun; 877(1):37-42. PubMed ID: 3013317
[TBL] [Abstract][Full Text] [Related]
11. Identification of (24E)-3 alpha,7 alpha-dihydroxy-5 beta-cholest-24-enoic acid and (24R,25S)-3 alpha,7 alpha,24-trihydroxy-5 beta-cholestanoic acid as intermediates in the conversion of 3 alpha,7 alpha-dihydroxy-5 beta-cholestanoic acid to chenodeoxycholic acid in rat liver homogenates.
Une M; Inoue A; Kurosawa T; Tohma M; Hoshita T
J Lipid Res; 1994 Apr; 35(4):620-4. PubMed ID: 8006516
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.
Diczfalusy U; Kase BF; Alexson SE; Björkhem I
J Clin Invest; 1991 Sep; 88(3):978-84. PubMed ID: 1885782
[TBL] [Abstract][Full Text] [Related]
13. Comparison of side chain oxidation of potential C27-bile acid intermediates between mitochondria and peroxisomes of the rat liver: presence of beta-oxidation activity for bile acid biosynthesis in mitochondria.
Une M; Konishi M; Yoshii M; Kuramoto T; Hoshita T
J Lipid Res; 1996 Dec; 37(12):2550-6. PubMed ID: 9017507
[TBL] [Abstract][Full Text] [Related]
14. Pool size, synthesis, and turnover of sulfated and nonsulfated cholic acid and chenodeoxycholic acid in patients with cirrhosis of the liver.
Stiehl A; Ast E; Czygan P; Fröhling W; Raedsch R; Kommerell B
Gastroenterology; 1978 Mar; 74(3):572-7. PubMed ID: 631488
[TBL] [Abstract][Full Text] [Related]
15. Zellweger's cerebro-hepato-renal syndrome--variations in expressivity and in defects of bile acid synthesis.
Gustafsson J; Gustavson KH; Karlaganis G; Sjövall J
Clin Genet; 1983 Nov; 24(5):313-9. PubMed ID: 6652941
[TBL] [Abstract][Full Text] [Related]
16. Peroxisomal oxidation of the steroid side chain in bile acid formation.
Pedersen JI
Biochimie; 1993; 75(3-4):159-65. PubMed ID: 8507677
[TBL] [Abstract][Full Text] [Related]
17. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Tint GS
Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
[TBL] [Abstract][Full Text] [Related]
18. [Cell biology from a medical viewpoint. XI. Peroxisomes: unmasking of a hidden organelle by studies of the Zellweger syndrome].
Wanders RJ
Ned Tijdschr Geneeskd; 1992 Jan; 136(4):164-8. PubMed ID: 1736126
[No Abstract] [Full Text] [Related]
19. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy.
Setchell KD; Heubi JE; Bove KE; O'Connell NC; Brewsaugh T; Steinberg SJ; Moser A; Squires RH
Gastroenterology; 2003 Jan; 124(1):217-32. PubMed ID: 12512044
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of bile acids in man. An in vivo evaluation of the conversion of R and S 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic and 3 alpha, 7 alpha, 12 alpha-24 xi-tetrahydroxy-5 beta-cholestanoic acids to cholic acid.
Swell L; Gustafsson J; Danielsson H; Schwartz CC; Vlahcevic ZR
J Biol Chem; 1981 Jan; 256(2):912-6. PubMed ID: 7005227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
